Skip to main content

Table 1 Patient Characteristics

From: Improve dosimetric outcome in stage III non-small-cell lung cancer treatment using spot-scanning proton arc (SPArc) therapy

Group

ID

Age

Location

TNM stage

Stage

ITV(cc)

Motion (cm)

SI

AP

LR

1

1

56

RUL

T3N2M0

IIIA

164.1

<  0.5

2

71

LUL

T1bN2M0

IIIA

107.0

3

75

LUL

T4N2M0

IIIB

822.8

4

49

RUL

T2aN2M0

IIIA

114.7

5

64

LLL

T3N2M0

IIIA

345.3

6

71

LLL

T2bN3M0

IIIB

265.4

7

51

LUL

T3N3M0

IIIB

366.5

8

56

RLL

T4N0M0

IIIA

276.7

2

9

66

RLL + RML

T4N2M0

IIIB

350.6

0.5

0

0

10

76

RML

T3N1M0

IIIA

157.1

0.7

0.1

0.1

11

55

LLL

T1aN2M0

IIIA

734.6

0.6

0.1

0

12

75

RUL

T2aN2M0

IIIA

77.4

0.5

0.2

0.1

13

60

LLL

T2N2M0

IIIA

269.1

1.3

0.1

0.1

14

50

RLL + RML

T4N2M0

IIIB

401.8

1.2

0.1

0.3

  1. Abbreviations: RUL right upper lobe, LUL left upper lobe, LLL left lower lobe, RLL right lower lobe, RML right middle lobe